Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Nov 5;19(1):119.
doi: 10.1186/s12902-019-0446-4.

The shape of the glucose response curve during an oral glucose tolerance test heralds β-cell function in a large Chinese population

Affiliations

The shape of the glucose response curve during an oral glucose tolerance test heralds β-cell function in a large Chinese population

Xinqi Cheng et al. BMC Endocr Disord. .

Abstract

Background: The shape of the glucose response curve during an oral glucose tolerance test (OGTT) can predict β-cell function and insulin resistance. However, there have been few studies conducted on Chinese people. Thus, we aimed to verify the usefulness of the glucose response curve in a large Chinese population.

Methods: A total of 9059 OGTT (3-h tests) were categorized into either a monophasic or a multiphasic group based on the shape of the glucose response. Homeostasis model assessments of fasting insulin resistance, the Matsuda Index, the insulinogenic index, and the disposition index were assessed by plasma glucose and serum insulin concentration obtained at fasting or during an OGTT.

Results: The shape of the OGTT glucose response curve was monophasic in 87.3% and multiphasic in 12.7% of participants. Individuals in the multiphasic group were younger compared to those in the monophasic group (38.6 ± 13.6 vs. 35.4 ± 13.5, P < 0.001). Individuals in the monophasic group had significantly higher fasting plasma glucose (FPG 5.6 ± 13.5 vs. 5.2 ± 0.6, P < 0.001), fasting insulin (FINS 14.8 ± 8.7 vs. 13.5 ± 7.9, P < 0.01), and homeostasis model assessment of insulin resistance (HOMA-IR 3.8 ± 2.6 vs. 3.1 ± 2.0, P < 0.001) and impaired β-cell function (disposition index 12.7 ± 14.1 vs. 16.6 ± 17.8, P < 0.001) compared to those in the multiphasic group.

Conclusion: The monophasic OGTT glucose response curve could reflect impaired β-cell function in a large Chinese population.

Keywords: Chinese; Glucose response curve; OGTT.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Study Flow Diagram OGTT: oral glucose tolerance test
Fig. 2
Fig. 2
Glucose during a 3-h OGTT in monophasic, biphasic and triphasic groups among different glycemic status. NGT: normal glucose tolerance, DM: diabetes mellitus
Fig. 3
Fig. 3
Proportion of multiphasic curves at different age group and glycemic status NGT: normal glucose tolerance, DM: diabetes mellitus

References

    1. Rehman K, Akash MS. Mechanisms of inflammatory responses and development of insulin resistance: how are they interlinked? J Biomed Sci. 2016;23:87. doi: 10.1186/s12929-016-0303-y. - DOI - PMC - PubMed
    1. Rehman K, Akash MSH. Mechanism of generation of oxidative stress and pathophysiology of type 2 diabetes mellitus: how are they interlinked? J Cell Biochem. 2017;118:3577–3585. doi: 10.1002/jcb.26097. - DOI - PubMed
    1. Schwartz SS, Epstein S, Corkey BE, Grant SF, Gavin JR, 3rd, Aguilar RB. The time is right for a new classification system for diabetes: rationale and implications of the beta-cell-centric classification schema. Diabetes Care. 2016;39:179–186. doi: 10.2337/dc15-1585. - DOI - PMC - PubMed
    1. Heise T, Zijlstra E, Nosek L, Heckermann S, Plum-Morschel L, Forst T. Euglycaemic glucose clamp: what it can and cannot do, and how to do it. Diabetes Obes Metab. 2016;18:962–972. doi: 10.1111/dom.12703. - DOI - PubMed
    1. Jia W, Weng J, Zhu D, Ji L, Lu J, Zhou Z, et al. Standards of medical care for type 2 diabetes in China 2019. Diabetes Metab Res Rev. 2019;35:e3158. doi: 10.1002/dmrr.3158. - DOI - PubMed